Salford Royal

Salford, Greater Manchester M6 8HD

1 studies enrolling now · 5 studies all time

What they study most

Alzheimer's Disease, Colitis, Ulcerative, Fabry Disease, Parkinson's Disease

Studies at this site

• A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients — Recruiting now
• Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease — Completed
• Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease — Stopped early
• 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis — Completed